Thermo Fisher Scientific (TMO) Total Liabilities (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Total Liabilities for 18 consecutive years, with $61.3 billion the latest figure, recorded in Q1 2026.

• Total Liabilities for Q1 2026 came in at $61.3 billion, up 23.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $61.3 billion (up 23.47% YoY), and the FY2025 annual result was $56.9 billion, up 19.17% from the prior year.
• Total Liabilities was $61.3 billion for Q1 2026 at Thermo Fisher Scientific, up from $56.9 billion in the prior quarter.
• Over five years, Total Liabilities peaked at $61.3 billion in Q1 2026 and troughed at $46.9 billion in Q4 2022.
• Average Total Liabilities over 5 years is $51.7 billion, with a median of $51.6 billion recorded in 2024.
• Year-over-year, Total Liabilities soared 67.61% in 2022 and decreased 8.14% in 2024.
• Over 5 years, Total Liabilities stood at $53.1 billion in 2022, then retreated by 2.11% to $52.0 billion in 2023, then dropped by 8.14% to $47.8 billion in 2024, then gained by 19.17% to $56.9 billion in 2025, then gained by 7.76% to $61.3 billion in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $61.3 billion in Q1 2026, $56.9 billion in Q4 2025, and $52.0 billion in Q3 2025.